Average stock performance after each discretionary buy, measured at 1, 3 and 6 months. 6 buys in history.
Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Beauty Health Co | 5,994,820 | reported | 16 Jun 2025 | tx 21+34,746,099−20,864,813 |
| Bausch & Lomb Corp | 978,389 | reported | 22 May 2026 | tx 19+2,141,052−217,700 |
| BridgeBio Pharma, Inc. | 104,921 | reported | 22 Jun 2022 | tx 4+262,639 |
| ARS Pharmaceuticals, Inc. | 30,000 | reported | 25 Jun 2025 | tx 8+974,597−240,000 |
| CISCO SYSTEMS, INC. | 24,143 | reported | 08 Dec 2022 | tx 6+30,540 |
| FOREST LABORATORIES INC | 0 | reported | 01 Jul 2014 | tx 21+962,103−962,103 |
| Actavis plc | 0 | reported | 08 May 2020 | tx 48+917,657.29−840,330.28 |
| Merck & Co., Inc. | 0 | reported | 03 Nov 2009 | tx 41+1,267,252−1,130,687.15 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 22 May 2026 | TAX_WITHHOLDING | Bausch & Lomb Corp | 2,886 | 15.92 USD | |
| 06 Mar 2026 | GRANT_AWARD | Bausch & Lomb Corp | 14,700 | 0.00 USD | |
| 06 Mar 2026 | PURCHASE | Bausch & Lomb Corp | 14,700 | 17.14 USD | |
| 26 Feb 2026 | TAX_WITHHOLDING | Bausch & Lomb Corp | 22,059 | 18.49 USD | |
| 27 Feb 2026 | TAX_WITHHOLDING | Bausch & Lomb Corp | 24,649 | 18.30 USD | |
| 25 Feb 2026 | GRANT_AWARD | Bausch & Lomb Corp | 327,102 | 0.00 USD | |
| 23 Feb 2026 | TAX_WITHHOLDING | Bausch & Lomb Corp | 65,444 | 17.99 USD | |
| 05 Aug 2025 | TAX_WITHHOLDING | Bausch & Lomb Corp | 4,231 | 14.44 USD | |
| 21 Jul 2025 | GRANT_AWARD | Bausch & Lomb Corp | 150,000 | 0.00 USD | deriv |
| 25 Jun 2025 | GRANT_AWARD | ARS Pharmaceuticals, Inc. | 30,000 | 0.00 USD | deriv |
| 16 Jun 2025 | GRANT_AWARD | Beauty Health Co | 73,051 | — | |
| 22 May 2025 | PURCHASE | Bausch & Lomb Corp | 22,000 | 11.28 USD | |
| 22 May 2025 | GRANT_AWARD | Bausch & Lomb Corp | 22,000 | 0.00 USD | |
| 20 May 2025 | EXERCISE | ARS Pharmaceuticals, Inc. | 120,000 | 1.01 USD | |
| 20 May 2025 | SALE | ARS Pharmaceuticals, Inc. | 120,000 | 14.25 USD | |
| 20 May 2025 | EXERCISE | ARS Pharmaceuticals, Inc. | 120,000 | 0.00 USD | deriv |
| 26 Feb 2025 | GRANT_AWARD | Bausch & Lomb Corp | 168,168 | 0.00 USD | |
| 26 Feb 2025 | GRANT_AWARD | Bausch & Lomb Corp | 600,858 | 0.00 USD | deriv |
| 23 Dec 2024 | TAX_WITHHOLDING | Bausch & Lomb Corp | 73,782 | 17.83 USD | |
| 23 Dec 2024 | TAX_WITHHOLDING | Bausch & Lomb Corp | 24,649 | 17.83 USD | |
| 12 Aug 2024 | PURCHASE | Beauty Health Co | 40,450 | 1.08 USD | |
| 05 Aug 2024 | GRANT_AWARD | Bausch & Lomb Corp | 32,250 | 0.00 USD | |
| 05 Aug 2024 | PURCHASE | Bausch & Lomb Corp | 32,250 | 15.66 USD | |
| 30 Jun 2022 | TAX_WITHHOLDING | Beauty Health Co | 3,076 | 12.86 USD | |
| 31 Mar 2022 | TAX_WITHHOLDING | Beauty Health Co | 3,711 | 16.88 USD |
3 purchases reported after at least 12 months of silence — most recent on 16 Aug 2023.